"World's Most Complete Market Research Reports Repository"

Global Pneumonia Vaccine Market Insights, Forecast to 2025

This report studies the global market size of Pneumonia Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumonia Vaccine in these regions.
This research report categorizes the global Pneumonia Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
In 2017, the global Pneumonia Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Pneumonia Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Pneumonia Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pneumonia Vaccine include
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions

Market Size Split by Type
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Market Size Split by Application
Pneumonia
Meningitis
Sepsis

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pneumonia Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Pneumonia Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pneumonia Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pneumonia Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Pneumonia Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pneumonia Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumonia Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Pneumonia Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pneumonia Vaccine Market Size Growth Rate by Type
1.4.2 Pneumococcal Conjugate Vaccine (PCV13)
1.4.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.5 Market by Application
1.5.1 Global Pneumonia Vaccine Market Size Growth Rate by Application
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Sepsis
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pneumonia Vaccine Market Size
2.1.1 Global Pneumonia Vaccine Revenue 2016-2025
2.1.2 Global Pneumonia Vaccine Sales 2016-2025
2.2 Pneumonia Vaccine Growth Rate by Regions
2.2.1 Global Pneumonia Vaccine Sales by Regions
2.2.2 Global Pneumonia Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Pneumonia Vaccine Sales by Manufacturers
3.1.1 Pneumonia Vaccine Sales by Manufacturers
3.1.2 Pneumonia Vaccine Sales Market Share by Manufacturers
3.1.3 Global Pneumonia Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Pneumonia Vaccine Revenue by Manufacturers
3.2.1 Pneumonia Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Pneumonia Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Pneumonia Vaccine Price by Manufacturers
3.4 Pneumonia Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumonia Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumonia Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Pneumonia Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Pneumonia Vaccine Sales by Type
4.2 Global Pneumonia Vaccine Revenue by Type
4.3 Pneumonia Vaccine Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Pneumonia Vaccine Breakdown Data by Application

6 North America
6.1 North America Pneumonia Vaccine by Countries
6.1.1 North America Pneumonia Vaccine Sales by Countries
6.1.2 North America Pneumonia Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pneumonia Vaccine by Type
6.3 North America Pneumonia Vaccine by Application
6.4 North America Pneumonia Vaccine by Company

7 Europe
7.1 Europe Pneumonia Vaccine by Countries
7.1.1 Europe Pneumonia Vaccine Sales by Countries
7.1.2 Europe Pneumonia Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pneumonia Vaccine by Type
7.3 Europe Pneumonia Vaccine by Application
7.4 Europe Pneumonia Vaccine by Company

8 Asia Pacific
8.1 Asia Pacific Pneumonia Vaccine by Countries
8.1.1 Asia Pacific Pneumonia Vaccine Sales by Countries
8.1.2 Asia Pacific Pneumonia Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pneumonia Vaccine by Type
8.3 Asia Pacific Pneumonia Vaccine by Application
8.4 Asia Pacific Pneumonia Vaccine by Company

9 Central & South America
9.1 Central & South America Pneumonia Vaccine by Countries
9.1.1 Central & South America Pneumonia Vaccine Sales by Countries
9.1.2 Central & South America Pneumonia Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pneumonia Vaccine by Type
9.3 Central & South America Pneumonia Vaccine by Application
9.4 Central & South America Pneumonia Vaccine by Company

10 Middle East and Africa
10.1 Middle East and Africa Pneumonia Vaccine by Countries
10.1.1 Middle East and Africa Pneumonia Vaccine Sales by Countries
10.1.2 Middle East and Africa Pneumonia Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pneumonia Vaccine by Type
10.3 Middle East and Africa Pneumonia Vaccine by Application
10.4 Middle East and Africa Pneumonia Vaccine by Company

11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.1.4 Pneumonia Vaccine Product Description
11.1.5 Recent Development
11.2 Glaxosmithkline Plc.
11.2.1 Glaxosmithkline Plc. Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.2.4 Pneumonia Vaccine Product Description
11.2.5 Recent Development
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.3.4 Pneumonia Vaccine Product Description
11.3.5 Recent Development
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.4.4 Pneumonia Vaccine Product Description
11.4.5 Recent Development
11.5 Serum Institute of India Pvt. Ltd.
11.5.1 Serum Institute of India Pvt. Ltd. Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.5.4 Pneumonia Vaccine Product Description
11.5.5 Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.6.4 Pneumonia Vaccine Product Description
11.6.5 Recent Development
11.7 Astellas Pharma Inc.
11.7.1 Astellas Pharma Inc. Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.7.4 Pneumonia Vaccine Product Description
11.7.5 Recent Development
11.8 Astrazeneca Plc.
11.8.1 Astrazeneca Plc. Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.8.4 Pneumonia Vaccine Product Description
11.8.5 Recent Development
11.9 CSL Limited
11.9.1 CSL Limited Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.9.4 Pneumonia Vaccine Product Description
11.9.5 Recent Development
11.10 Emergent Biosolutions
11.10.1 Emergent Biosolutions Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Pneumonia Vaccine
11.10.4 Pneumonia Vaccine Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Pneumonia Vaccine Raw Material
13.1.2 Pneumonia Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Picture of Pneumonia Vaccine
Figure Global Pneumonia Vaccine Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Pneumonia Vaccine Production Market Share by Types (Product Category) in 2017
Figure Pneumococcal Conjugate Vaccine (PCV13) Product Picture
Table Major Manufacturers of Pneumococcal Conjugate Vaccine (PCV13)
Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Product Picture
Table Major Manufacturers of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table Global Pneumonia Vaccine Market Size Growth Rate by Application 2018-2025 (K Doses)
Figure Pneumonia
Figure Meningitis
Figure Sepsis
Figure Pneumonia Vaccine Report Years Considered
Figure Global Pneumonia Vaccine Market Size 2016-2025 (Million US$)
Figure Global Pneumonia Vaccine Sales 2016-2025 (K Doses)
Table Global Pneumonia Vaccine Market Size by Regions 2016-2025 (K Doses) & (Million US$)
Table Global Pneumonia Vaccine Sales by Regions 2016-2025 (K Doses)
Table Global Pneumonia Vaccine Sales Market Share by Regions 2016-2025
Figure Global Pneumonia Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Pneumonia Vaccine Sales Market Share by Regions
Table Global Pneumonia Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Pneumonia Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Pneumonia Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Pneumonia Vaccine Revenue Market Share by Regions
Table Global Pneumonia Vaccine Sales by Manufacturers (2016-2018) (K Doses)
Table Global Pneumonia Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Pneumonia Vaccine Sales Share by Manufacturers in 2017
Table Pneumonia Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Pneumonia Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Pneumonia Vaccine Value Share by Manufacturers in 2017
Table Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Pneumonia Vaccine Price (2016-2018) (USD/Dose)
Table Pneumonia Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pneumonia Vaccine Product Category
Table Date of International Manufacturers Enter into Pneumonia Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pneumonia Vaccine Sales by Type (2016-2025) (K Doses)
Table Global Pneumonia Vaccine Sales Share by Type (2016-2025)
Figure Global Pneumonia Vaccine Sales Market Share by Type (2016-2025)
Figure Global Pneumonia Vaccine Sales Market Share by Type in 2017
Table Global Pneumonia Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Pneumonia Vaccine Revenue Share by Type (2016-2025)
Figure Global Pneumonia Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Pneumonia Vaccine Revenue Market Share by Type in 2017
Table Pneumonia Vaccine Price by Type 2013-2018 (USD/Dose)
Table Global Pneumonia Vaccine Sales by Application (2016-2025) (K Doses)
Table Global Pneumonia Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Pneumonia Vaccine Market Share by Application (2016-2025)
Figure Global Sales Pneumonia Vaccine Market Share by Application (2016-2025)
Figure North America Pneumonia Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure North America Pneumonia Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Pneumonia Vaccine Sales by Countries (2016-2025) (K Doses)
Table North America Pneumonia Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Pneumonia Vaccine Sales Market Share by Countries
Table North America Pneumonia Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Pneumonia Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Pneumonia Vaccine Revenue Market Share by Countries
Figure United States Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure United States Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Canada Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Mexico Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Pneumonia Vaccine Sales by Type (2016-2025) (K Doses)
Table North America Pneumonia Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Pneumonia Vaccine Market Share by Type
Table North America Pneumonia Vaccine Sales by Application (2016-2025) (K Doses)
Table North America Pneumonia Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Pneumonia Vaccine Market Share by Application
Table North America Pneumonia Vaccine Sales by Company (2016-2018) (K Doses)
Table North America Pneumonia Vaccine Sales Market Share by Company (2016-2018)
Figure North America Pneumonia Vaccine Sales Market Share by Company in 2017
Figure Europe Pneumonia Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Europe Pneumonia Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Pneumonia Vaccine Sales by Countries (2016-2025) (K Doses)
Table Europe Pneumonia Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Pneumonia Vaccine Sales Market Share by Countries
Table Europe Pneumonia Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Pneumonia Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Pneumonia Vaccine Revenue Market Share by Countries
Figure Germany Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Germany Pneumonia Vaccine Revenue Growth Rate (2016-2025) (K Doses)
Figure France Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure France Pneumonia Vaccine Revenue Growth Rate (2016-2025) (K Doses)
Figure UK Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure UK Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Italy Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Russia Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Pneumonia Vaccine Sales by Type (2016-2025) (K Doses)
Table Europe Pneumonia Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Pneumonia Vaccine Market Share by Type
Table Europe Pneumonia Vaccine Sales by Application (2016-2025) (K Doses)
Table Europe Pneumonia Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Pneumonia Vaccine Market Share by Application
Table Europe Pneumonia Vaccine Sales by Company (2016-2018) (K Doses)
Table Europe Pneumonia Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Pneumonia Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Pneumonia Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Asia Pacific Pneumonia Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Pneumonia Vaccine Sales by Countries (2016-2025) (K Doses)
Table Asia Pacific Pneumonia Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Pneumonia Vaccine Sales Market Share by Countries
Table Asia Pacific Pneumonia Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Pneumonia Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Pneumonia Vaccine Revenue Market Share by Countries
Figure China Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure China Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Japan Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Korea Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure India Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Australia Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Indonesia Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Malaysia Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Philippines Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Thailand Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Vietnam Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Singapore Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Pneumonia Vaccine Sales by Type (2016-2025) (K Doses)
Table Asia Pacific Pneumonia Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Pneumonia Vaccine Market Share by Type
Table Asia Pacific Pneumonia Vaccine Sales by Application (2016-2025) (K Doses)
Table Asia Pacific Pneumonia Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Pneumonia Vaccine Market Share by Application
Table Asia Pacific Pneumonia Vaccine Sales by Company (2016-2018) (K Doses)
Table Asia Pacific Pneumonia Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Pneumonia Vaccine Sales Market Share by Company in 2017
Figure Central & South America Pneumonia Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Central & South America Pneumonia Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Pneumonia Vaccine Sales by Countries (2016-2025) (K Doses)
Table Central & South America Pneumonia Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Pneumonia Vaccine Sales Market Share by Countries
Table Central & South America Pneumonia Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Pneumonia Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Pneumonia Vaccine Revenue Market Share by Countries
Figure Brazil Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Brazil Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Argentina Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Pneumonia Vaccine Sales by Type (2016-2025) (K Doses)
Table Central & South America Pneumonia Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Pneumonia Vaccine Market Share by Type
Table Central & South America Pneumonia Vaccine Sales by Application (2016-2025) (K Doses)
Table Central & South America Pneumonia Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Pneumonia Vaccine Market Share by Application
Table Central & South America Pneumonia Vaccine Sales by Company (2016-2018) (K Doses)
Table Central & South America Pneumonia Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Pneumonia Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Pneumonia Vaccine Sales Growth Rate 2016-2025 (K Doses)
Figure Middle East and Africa Pneumonia Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Pneumonia Vaccine Sales by Countries (2016-2025) (K Doses)
Table Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries
Table Middle East and Africa Pneumonia Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries
Figure GCC Countries Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure GCC Countries Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Turkey Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure Egypt Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Pneumonia Vaccine Sales Growth Rate (2016-2025) (K Doses)
Figure South Africa Pneumonia Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Pneumonia Vaccine Sales by Type (2016-2025) (K Doses)
Table Middle East and Africa Pneumonia Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Pneumonia Vaccine Market Share by Type
Table Middle East and Africa Pneumonia Vaccine Sales by Application (2016-2025) (K Doses)
Table Middle East and Africa Pneumonia Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Pneumonia Vaccine Market Share by Application
Table Middle East and Africa Pneumonia Vaccine Sales by Company (2016-2018) (K Doses)
Table Middle East and Africa Pneumonia Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Pneumonia Vaccine Sales Market Share by Company in 2017
Table Pfizer Inc. Company Details
Table Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Pfizer Inc. Recent Development
Table Glaxosmithkline Plc. Company Details
Table Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Glaxosmithkline Plc. Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Merck & Co., Inc. Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Sanofi Pasteur Recent Development
Table Serum Institute of India Pvt. Ltd. Company Details
Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Serum Institute of India Pvt. Ltd. Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Astellas Pharma Inc. Company Details
Table Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Astellas Pharma Inc. Recent Development
Table Astrazeneca Plc. Company Details
Table Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Astrazeneca Plc. Recent Development
Table CSL Limited Company Details
Table CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table CSL Limited Recent Development
Table Emergent Biosolutions Company Details
Table Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Emergent Biosolutions Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Pneumonia Vaccine Value Chain
Table Typical Suppliers of Key Pneumonia Vaccine Raw Material
Table Pneumonia Vaccine Customers List
Table Pneumonia Vaccine Sales Channels
Table Pneumonia Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type